Fiona Langlands1, Eleanor Cornford2, Emad Rakha3, Barbara Dall4, Eleanor Gutteridge5, David Dodwell6, Abeer M Shaaban7, Nisha Sharma4. 1. 1 Department of Breast Surgery, St James's Hospital, Leeds, UK. 2. 2 Department of Radiology, Nottingham Breast Institute, Nottingham University Hospitals NHS Trust, Nottingham, UK. 3. 3 Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham, UK. 4. 4 Leeds/Wakefield Breast Screening Unit, Seacroft Hospital, Leeds, UK. 5. 5 Department of Breast Surgery, Nottingham University Hospitals, Nottingham, UK. 6. 6 St James's Institute of Oncology, St James's Hospital, Leeds, UK. 7. 7 Department of Histopathology, Queen Elizabeth Hospital Birmingham, Birmingham, UK.
Abstract
OBJECTIVE: : To review the clinical presentation, baseline imaging features, surgical management and final surgical pathology of metaplastic carcinoma of the breast. METHODS: : A total of 71 cases were identified over a 10-year period from two major UK breast cancer institutions. Imaging at diagnosis including mammography, ultrasound, MRI and CT scans and histological diagnosis were reviewed. Follow-up data including local and systemic recurrence were retrieved. RESULTS: : Of the 71 cases, 60 (84.5%) cases presented with a palpable lump. 60 (84.5%) cases showed a mass on mammography, of whom 47 (78.3%) cases were ill defined and 17.0% cases showed calcifications associated with a mass lesion. All 71 cases were seen as a mass on ultrasound. The imaging score was R3 or R4 in 26 cases and R5 in 47 cases. 16 patients underwent MRI with most (93.8%) showing a solid mass with central necrosis. No metastatic disease was seen in the 13 patients who underwent staging CT. Despite having a larger size, 50% of the cases successfully underwent breast conservative surgery. Positive axillary lymph nodes were seen in 11 (15.5%) cases. CONCLUSION: : In this series, metaplastic cancers were palpable in 85% cases, tended to be large at the time of presentation and imaging showed characteristics of malignancy. Only 11 (15.5%) cases had nodal involvement. ADVANCES IN KNOWLEDGE:: Metaplastic carcinomas are often palpable and of large size at the time of presentation. Metaplastic carcinomas raise the concern for malignancy on mammography and ultrasound, warranting further biopsy. Metaplastic carcinomas tend to be grade 3 and triple receptor negative.
OBJECTIVE: : To review the clinical presentation, baseline imaging features, surgical management and final surgical pathology of metaplastic carcinoma of the breast. METHODS: : A total of 71 cases were identified over a 10-year period from two major UK breast cancer institutions. Imaging at diagnosis including mammography, ultrasound, MRI and CT scans and histological diagnosis were reviewed. Follow-up data including local and systemic recurrence were retrieved. RESULTS: : Of the 71 cases, 60 (84.5%) cases presented with a palpable lump. 60 (84.5%) cases showed a mass on mammography, of whom 47 (78.3%) cases were ill defined and 17.0% cases showed calcifications associated with a mass lesion. All 71 cases were seen as a mass on ultrasound. The imaging score was R3 or R4 in 26 cases and R5 in 47 cases. 16 patients underwent MRI with most (93.8%) showing a solid mass with central necrosis. No metastatic disease was seen in the 13 patients who underwent staging CT. Despite having a larger size, 50% of the cases successfully underwent breast conservative surgery. Positive axillary lymph nodes were seen in 11 (15.5%) cases. CONCLUSION: : In this series, metaplastic cancers were palpable in 85% cases, tended to be large at the time of presentation and imaging showed characteristics of malignancy. Only 11 (15.5%) cases had nodal involvement. ADVANCES IN KNOWLEDGE:: Metaplastic carcinomas are often palpable and of large size at the time of presentation. Metaplastic carcinomas raise the concern for malignancy on mammography and ultrasound, warranting further biopsy. Metaplastic carcinomas tend to be grade 3 and triple receptor negative.
Authors: Alberto Luini; Marisel Aguilar; Giovanna Gatti; Roberta Fasani; Edoardo Botteri; Jack Antonio Diaz Brito; Patrick Maisonneuve; Anna Rita Vento; Giuseppe Viale Journal: Breast Cancer Res Treat Date: 2006-09-29 Impact factor: 4.872
Authors: Wei Tse Yang; Bryan Hennessy; Kristine Broglio; Chadwick Mills; Nour Sneige; W Grant Davis; Vicente Valero; Kelly K Hunt; Michael Z Gilcrease Journal: AJR Am J Roentgenol Date: 2007-12 Impact factor: 3.959
Authors: Willard Wong; Edi Brogi; Jorge S Reis-Filho; George Plitas; Mark Robson; Larry Norton; Monica Morrow; Hannah Y Wen Journal: NPJ Breast Cancer Date: 2021-07-22